Antithrombotic agents

Patent 4210670 Issued on July 1, 1980. Estimated Expiration Date:

June 23, 1998. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

3337406

Inventor

Cooke, Ernest

Assignee

Astra Lakemedel Aktiebolag

Application

No. 05/918476 filed on 06/23/1978

US Classes:

514/626, Nitrogen in R514/330C=X bonded directly to the piperidine ring (X is chalcogen)

Examiners

Primary: Friedman, Stanley J.

Attorney, Agent or Firm

Brumbaugh, Graves, Donohue & Raymond

International Classes

A61K 31/165 (20060101)
A61K 31/445 (20060101)

Foreign Application Priority Data

1977-07-06 SE

Abstract

The invention relates to a method for prophylactic treatment in order to eliminate the formation of tromboses and embolis in deep veins after surgical incisions in lower body regions, whereby a local anesthetic compound of the group consisting of lidocaine, mepivacaine, bupivacaine, tocainide, prilocaine, and ethidocaine is administered, as well as pharmaceutical preparations herefore.

Other References

Laaksonen et al. "Effect of Anaesthesia on the Incidence of Postoperative Lower Limb Thrombosis"
Chem. Abst., vol. 84, No. 174006f, McDevitt et al., (1976)
Chem. Abst., vol. 85, No. 56502n, Lalka et al., (1976)
Chem. Abst., vol. 71, No. 100120y, Robison et al. (1969)